So we welcome you back to the committee. Its good to have discussion with you last week. I want to thank you really want to thank you for all youve done at the department, for your willingness to serve to this point, and for your willingness to step up in this new and higher capacity. Weve got our colleagues here this morning to introduce the deputy secretary, both texas and louisiana are well represented. Mr. Deputy secretary, you should feel very welcome by having these gentlemen next to you. So we will start with senator cassidy up here at the dais followed by senators cruz and kennedy to introduce the deputy secretary this morning. So senator cassidy, if you would like to proceed. We do have a full complement here this morning and a full house behind you. Hopefully the introductions do not consume our full morning, but we certainly welcome all the good comments. So senator cassidy. Madam chair, what a wonderful way to tell me to be brief. But its a privilege to represent my fellow
Leading us off today. I think nothing could be better, really. I know were going to hear insights and suggestions and everybodys going to bevery energetic. So please welcome. First of all and i think theyre coming in from the side, doctor jenny columbo, Vice President of global patients and Scientific Affairs at kl pharmaceutical michelle ashman, the director federal advocacy and Alliance Development eli lilly. Doctor gwen nichols, chief medical officer at the leukemia and lymphoma society. Doctor erin oshea, president of the Howard Hughes institute. Doctor peggy amber, foreign secretary of the National Academy of medicineand former commissioner of the fda. And doctor janine clayton, director of the office of research on womens health. Our moderator this morning is doctor loosen the main. The evp and ceo of American Association of colleges pharmacy and im proud to say board member of Research America. Thank you all leaders, we look forward to this. My thanks to the organizers of the fo
So please welcome, first of all, and to think theyre coming in from the side, dr. Jenny colombo, the Vice President global patients and Scientific Affairs at takeda pharmaceuticals. Michele oshman, the director, federal advocacy and Alliance Development at eli lilly. Dr. Gwen nichols, the chief medical officer at the leukemia and lymphoma society. Doctor erin oshea, president of the Howard Hughes medical institute. Doctor peggy hamburg, the foreign secretary of the National Academy of medicine and former commissioner of the fda. And doctor janine clayton, director of the nih office of research on womens health. Our moderator this morning is lucinda maine, ceo of the American Association of colleges of pharmacy, and the pride to say boardmember of research america. Thank you all leaders. We look forward to this. My thanks really to organizers of the forum this year for giving us an opportunity to talk about some things we dont talk about so much, and we have an exemplary panel that brin
Its a special privilege, and this feels really good to be kicking off our first panel. Up panel of Women Leaders are starting us off today. Nothing could be better. I know we are going to hear inside , suggestions, and evidence could be very energized. Please welcome first of all, i think theyre coming in from the side. Dr. Jenny columbo, the director of federal accuracy and alliance , dr. Glenn nichols, dr. Peggy hamburg thank you all. We look forward to this. And thank you to our moderator mary wooley. I like to thank the organizers of the form for giving us an opportunity to talk about topics we dont talk about very much. We have an exemplary panel that brings experience from the public and private sectors. And i look forward to moderating the conversation. By way of the background. 50 of the phds that have been awarded in biology have gone to women. Yet it goes without saying that in some respects that you are an exception to the rule of women rising to important positions of leade
Proposed fiscal year 2018 budget. Members asked questions about the proposed cuts of the budget as well as to where to store the ations Nuclear Waste. The committee will come to order. I apologize for the delayed start. But hopefully we will have an opportunity to hear from the of the and learn president s views for the department of energy. Secretary perry, i want to welcome you to your first hearing following your bipartisan confirmation here in the senate. It took us a little bit longer, we are grad to have you at the helm and getting a full complement of folks there at the department. The budget request for the department of energy takes a different approach. The president has made a concerted effort to increase funding for the National Nuclear facility. This is a portion of the department that falls outside the scope of our committee here. The administration has requested robust funding for the cleanup of Nuclear Waste left behind by our countrys cold war legacy. The budget reques